Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry.

[1]  K. Kuck,et al.  Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: Analysis from the german transcatheter aortic valve interventions registry , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  F. Santini,et al.  Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. , 2013, International journal of cardiology.

[3]  P. Pibarot,et al.  Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. , 2013, The American journal of cardiology.

[4]  B. Lytle,et al.  A comprehensive review of the PARTNER trial. , 2013, Journal of Thoracic and Cardiovascular Surgery.

[5]  Jessica L. Howard,et al.  Quantitative evaluation of change in coexistent mitral regurgitation after aortic valve replacement. , 2013, The Journal of thoracic and cardiovascular surgery.

[6]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[7]  A. Colombo,et al.  Comparison of variables in men versus women undergoing transcatheter aortic valve implantation for severe aortic stenosis (from Italian Multicenter CoreValve registry). , 2013, The American journal of cardiology.

[8]  P. Serruys,et al.  Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. , 2012, The American journal of cardiology.

[9]  D. Wood,et al.  Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. , 2012, Journal of the American College of Cardiology.

[10]  P. Serruys,et al.  Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. , 2012, American heart journal.

[11]  A. Schmermund,et al.  Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  P. Jüni,et al.  Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. , 2012, JACC. Cardiovascular interventions.

[13]  J. Rodés‐Cabau,et al.  Transcatheter aortic valve implantation and cerebrovascular events: the current state of the art , 2012, Annals of the New York Academy of Sciences.

[14]  K. Kuwaki,et al.  Predictors of Early and Mid‐Term Results in Contemporary Aortic Valve Replacement for Aortic Stenosis , 2012, Journal of cardiac surgery.

[15]  M. Morice,et al.  Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. , 2012, Journal of the American College of Cardiology.

[16]  M. Jiménez-Navarro,et al.  Survival and predictive factors of mortality after 30 days in patients treated with percutaneous implantation of the CoreValve aortic prosthesis. , 2012, American heart journal.

[17]  R. Hetzer,et al.  Transapical Aortic Valve Implantation Incidence and Predictors of Paravalvular Leakage and Transvalvular Regurgitation in a Series of 358 Patients , 2011 .

[18]  O. Alfieri,et al.  The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[19]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[20]  Howard K. Song,et al.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. , 2011, The Annals of thoracic surgery.

[21]  Joanna Chikwe,et al.  Frailty: the missing element in predicting operative mortality. , 2010, Seminars in thoracic and cardiovascular surgery.

[22]  A. Kaider,et al.  Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis , 2009, Thrombosis and Haemostasis.

[23]  M. Ruel,et al.  Gender differences in the long-term outcomes after valve replacement surgery , 2008, Heart.

[24]  A. Speir,et al.  Institutional report-Cardiopulmonary bypass The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score : the gender factor , 2007 .

[25]  A. Gonzalez,et al.  Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. , 2005, The Journal of thoracic and cardiovascular surgery.

[26]  M. Swaminathan,et al.  The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. , 2003, The Annals of thoracic surgery.